Surinder Pada

Ng Teng Fong General Hospital - Division of Infectious Diseases

Singapore

SCHOLARLY PAPERS

4

DOWNLOADS

768

SSRN CITATIONS

7

CROSSREF CITATIONS

0

Scholarly Papers (4)

1.

Immunological and Viral Correlates of COVID-19 Disease Severity: A Prospective Cohort Study of the First 100 Patients in Singapore

Number of pages: 34 Posted: 20 May 2020
National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Duke NUS Medical School, Duke-NUS Medical School - Programme in Emerging Infectious Diseases, National Centre for Infectious Diseases, Singapore, Ministry of Health, Singapore, National Centre for Infectious Diseases, Singapore, Singapore General Hospital - Department of Infectious Diseases, National University Health System (NUHS), Ng Teng Fong General Hospital - Division of Infectious Diseases, Changi General Hospital, Alexandra Hospital, Khoo Teck Puat Hospital, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Duke NUS Medical School, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases, National University of Singapore (NUS), Singapore General Hospital, National Centre for Infectious Diseases, Singapore, Tan Tock Seng Hospital, National Centre for Infectious Diseases, National University of Singapore (NUS) - Department of Microbiology and Immunology, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Duke NUS Medical School, National Centre for Infectious Diseases and Independent
Downloads 600 (63,790)
Citation 5

Abstract:

Loading...

Coronavirus Disease 2019; COVID-19; severe acute respiratory syndrome coronavirus 2; SARS-CoV-2; severe; critical illness; IL-6; serology; viral culture

2.

Linear B-Cell Epitopes in the Spike and Nucleocapsid Proteins as Markers of SARS-CoV-2 Exposure and Disease Severity

Number of pages: 38 Posted: 12 Jun 2020
Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases, Singapore, Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases, National Centre for Infectious Diseases, Singapore General Hospital - Department of Infectious Diseases, Ng Teng Fong General Hospital - Division of Infectious Diseases, Changi General Hospital, Alexandra Hospital, National University of Singapore (NUS) - Department of Microbiology and Immunology, National Centre for Infectious Diseases, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN) and Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN)
Downloads 113 (333,456)
Citation 4

Abstract:

Loading...

epitopes; SARS-CoV-2; COVID-19; patients; biomarkers

3.

Association of SARS-CoV-2 Clades with Clinical, Inflammatory and Virologic Outcomes: An Observational Study

Number of pages: 33 Posted: 05 Jan 2021
National Centre for Infectious Diseases, Singapore, National Public Health and Epidemiology Unit, National Centre for Infectious Diseases, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases, Singapore, Duke NUS Medical School, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Government of the Republic of Singapore - Communicable Diseases Division, Ministry of Health, Singapore, National Centre for Infectious Diseases, Singapore, Duke NUS Medical School, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Singapore General Hospital - Department of Infectious Diseases, Ng Teng Fong General Hospital - Division of Infectious Diseases, National University Health System, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Khoo Teck Puat Hospital, Changi General Hospital - Department of Infectious Diseases, Alexandra Hospital, Duke-NUS Medical School, National Centre for Infectious Diseases, National University of Singapore (NUS) - Department of Microbiology and Immunology, Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Duke NUS Medical School, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Bioinformatics Institute, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine and Ministry of Health, Singapore
Downloads 40 (571,812)

Abstract:

Loading...

4.

Sensitive Detection of Total Anti-Spike Antibodies and Isotype Switching in Asymptomatic and Symptomatic COVID-19 Patients

Number of pages: 44 Posted: 23 Oct 2020
Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, National Centre for Infectious Diseases, National Centre for Infectious Diseases, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore General Hospital - Department of Infectious Diseases, Ng Teng Fong General Hospital - Division of Infectious Diseases, Changi General Hospital - Department of Infectious Diseases, Alexandra Hospital, National Centre for Infectious Diseases, National University of Singapore (NUS) - Department of Microbiology and Immunology, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases and Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre
Downloads 15 (742,191)

Abstract:

Loading...

SARS-CoV-2, COVID-19, serological, S protein, antibodies, IgG subclasses, symptomatic, asymptomatic